1. Home
  2. CTKB vs CTO Comparison

CTKB vs CTO Comparison

Compare CTKB & CTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • CTO
  • Stock Information
  • Founded
  • CTKB 1990
  • CTO 1902
  • Country
  • CTKB United States
  • CTO United States
  • Employees
  • CTKB N/A
  • CTO N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CTO Real Estate Investment Trusts
  • Sector
  • CTKB Health Care
  • CTO Real Estate
  • Exchange
  • CTKB Nasdaq
  • CTO Nasdaq
  • Market Cap
  • CTKB 718.8M
  • CTO 589.6M
  • IPO Year
  • CTKB 2021
  • CTO N/A
  • Fundamental
  • Price
  • CTKB $2.83
  • CTO $18.43
  • Analyst Decision
  • CTKB Hold
  • CTO Strong Buy
  • Analyst Count
  • CTKB 4
  • CTO 3
  • Target Price
  • CTKB $6.00
  • CTO $22.33
  • AVG Volume (30 Days)
  • CTKB 1.1M
  • CTO 206.2K
  • Earning Date
  • CTKB 05-08-2025
  • CTO 07-24-2025
  • Dividend Yield
  • CTKB N/A
  • CTO 8.25%
  • EPS Growth
  • CTKB N/A
  • CTO N/A
  • EPS
  • CTKB N/A
  • CTO N/A
  • Revenue
  • CTKB $197,050,000.00
  • CTO $132,203,000.00
  • Revenue This Year
  • CTKB $3.25
  • CTO $19.25
  • Revenue Next Year
  • CTKB $8.58
  • CTO $8.47
  • P/E Ratio
  • CTKB N/A
  • CTO N/A
  • Revenue Growth
  • CTKB N/A
  • CTO 17.48
  • 52 Week Low
  • CTKB $2.37
  • CTO $16.12
  • 52 Week High
  • CTKB $7.63
  • CTO $21.15
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 43.14
  • CTO 55.77
  • Support Level
  • CTKB $2.37
  • CTO $17.46
  • Resistance Level
  • CTKB $2.61
  • CTO $18.59
  • Average True Range (ATR)
  • CTKB 0.18
  • CTO 0.30
  • MACD
  • CTKB 0.04
  • CTO 0.06
  • Stochastic Oscillator
  • CTKB 63.45
  • CTO 85.40

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About CTO CTO Realty Growth Inc.

CTO Realty Growth Inc is a real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.

Share on Social Networks: